Estrogen and Graft Atherosclerosis Research Trial (EAGER)

NCT00000605 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cardiovascular Diseases
Coronary Arteriosclerosis
Coronary Disease
Heart Diseases
Myocardial Ischemia
Postmenopause

Interventions

DRUG: hormone replacement therapy
DRUG: estrogens
DRUG: medroxyprogesterone

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)